Keystone Nano
Senior financial executive with more than 40 years of investment banking and public accounting experience. Have represented clients in more than $10 billion of financing and M&A transactions. Licensed securities industry professional with significant experience raising capital for early-stage companies.
This person is not in any teams
This person is not in any offices
Keystone Nano
KN is developing products to treat cancer with unique, effective, targeted nano therapies and is starting clinical testing in 2016.